Trial intelligence / Profile preview

SPORT: Supplements vs. Rosuvastatin for Cholesterol Health

NCT04846231Phase 2Completed

Sponsor
Cleveland Clinic
Start
Apr 2021
Primary completion
Jul 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of rosuvastatin in hypercholesterolemia, sponsored by Cleveland Clinic. Started Apr 2021; status: completed.

02

Drugs

rosuvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT04846231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04846231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call